A Phase 1 interventional study of Bupropion and Mecamylamine in Smoking, sponsored by US Department of Veterans Affairs. Completed at 1 site in United States. Open to participants aged 20 Years to 40 Years. Per ClinicalTrials.gov, last updated 2009-01-21.
Sponsored by US Department of Veterans Affairs · Phase 1, Interventional, and Treatment
The purpose of this study is to test the effectiveness of a combination of the drugs bupropion and mecamylamine along with a nicotine patch as a therapy for smoking cessation.
325 studies on the registry are indexed under Smoking; 141 are open to participants now.
Browse Smoking studies →US Department of Veterans Affairs is the lead sponsor of 675 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Subjects must be a smoker between 20 and 40 years old, have smoked at least 20 cigarettes per day for at least 2 years, wish to stop smoking and be in good general health
This study is completed, as verified in May 2007. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
US Department of Veterans Affairs →